We are live on ! Find out more
TECH icon

Bio-Techne

556 hedge funds and large institutions have $16.2B invested in Bio-Techne in 2022 Q1 according to their latest regulatory filings, with 65 funds opening new positions, 199 increasing their positions, 209 reducing their positions, and 76 closing their positions.

New
Increased
Maintained
Reduced
Closed

269% more call options, than puts

Call options by funds: $30.2M | Put options by funds: $8.18M

8.03% more ownership

Funds ownership: 376.15%384.18% (+8%)

5% less repeat investments, than reductions

Existing positions increased: 199 | Existing positions reduced: 209

3% less funds holding

Funds holding: 575556 (-19)

14% less first-time investments, than exits

New positions opened: 65 | Existing positions closed: 76

15% less capital invested

Capital invested by funds: $19.1B → $16.2B (-$2.9B)

20% less funds holding in top 10

Funds holding in top 10: 1512 (-3)

Holders
556
Holders Change
-19
Holders Change %
-3.3%
% of All Funds
8.77%
Holding in Top 10
12
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-20%
% of All Funds
0.19%
New
65
Increased
199
Reduced
209
Closed
76
Calls
$30.2M
Puts
$8.18M
Net Calls
+$22M
Net Calls Change
+$14.6M
Name Holding Trade Value Shares
Change
Change in
Stake
SRC
126
Stone Run Capital
New York
$9.67M +$10.3K +100 +0.1%
Canada Life
127
Canada Life
Manitoba, Canada
$9.58M -$299K -2,900 -3%
Ohio Public Employees Retirement System (OPERS)
128
Ohio Public Employees Retirement System (OPERS)
Ohio
$9.23M -$1.1M -10,652 -11%
Mitsubishi UFJ Asset Management
129
Mitsubishi UFJ Asset Management
Japan
$9.06M +$708K +6,860 +9%
SCM
130
Sandler Capital Management
New York
$9.02M -$17M -164,400 -66%
LIM
131
Leavell Investment Management
Alabama
$8.94M +$4.13K +40 +0%
Schroder Investment Management Group
132
Schroder Investment Management Group
United Kingdom
$8.73M +$3.63M +35,204 +80%
BMSSC
133
B. Metzler seel. Sohn & Co
Germany
$8.69M +$144K +1,400 +2%
Robeco Institutional Asset Management
134
Robeco Institutional Asset Management
Netherlands
$8.68M -$2.65M -25,692 -24%
Toronto Dominion Bank
135
Toronto Dominion Bank
Ontario, Canada
$8.49M +$43.7K +424 +0.5%
KCM
136
Kornitzer Capital Management
Kansas
$8.27M -$175K -1,692 -2%
Victory Capital Management
137
Victory Capital Management
Texas
$8.11M -$1.27M -12,328 -13%
GC
138
Guggenheim Capital
Illinois
$8.11M -$881K -8,540 -10%
Mitsubishi UFJ Trust & Banking
139
Mitsubishi UFJ Trust & Banking
Japan
$8.02M -$319K -3,092 -4%
CS
140
Candriam SCA
Luxembourg
$7.99M -$21.5M -208,100 -76%
CRC
141
Curi RMB Capital
Illinois
$7.89M -$388K -3,764 -5%
Aviva
142
Aviva
United Kingdom
$7.49M +$640K +6,208 +10%
CF
143
Covea Finance
France
$7.46M
Nisa Investment Advisors
144
Nisa Investment Advisors
Missouri
$7.39M +$334K +3,240 +5%
Pacer Advisors
145
Pacer Advisors
Pennsylvania
$7.3M +$3.33M +32,240 +92%
OAM
146
Oppenheimer Asset Management
New York
$7.24M -$300K -2,908 -4%
Asset Management One
147
Asset Management One
Japan
$7.06M -$81.7K -792 -1%
SOADOR
148
State of Alaska Department of Revenue
Alaska
$6.94M -$1.98M -19,204 -23%
AB
149
Amalgamated Bank
New York
$6.73M +$117K +1,132 +2%
AF
150
Amalgamated Financial
New York
$6.73M +$6.41M +62,160 New

TECH Hedge Fund Activity: Q1 2022 in Review

556 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q1 2022, worth a combined $16.2B — down 15% from $19.1B a quarter earlier.

Sellers outnumbered buyers: 76 funds closed out of TECH and 65 opened new positions — a net loss of 11 holders — while 209 trimmed existing stakes and 199 added.

The largest buyer was Select Equity Group, opening a new position worth an estimated $288M. The largest seller was Marshall Wace, cutting an estimated $125M.

  • 556 institutional investors held Bio-Techne (TECH) as of Q1 2022, down from 575 in Q4 2021.
  • Funds reported $16.2B of Bio-Techne stock for Q1 2022, down 15% quarter-over-quarter.
  • 65 funds opened new Bio-Techne positions in Q1 2022 and 76 closed out, a net change of -11 holders.
  • The largest Bio-Techne buyer in Q1 2022 was Select Equity Group, an estimated $288M added.
  • The largest Bio-Techne seller in Q1 2022 was Marshall Wace, an estimated $125M sold.

Based on aggregated 13F filings for Q1 2022.